AXSM Axsome Corp Future Profit
Axsome Therapeutics (AXSM) is strengthening its leadership status in neuromedicine due to physician recognition of its migraine treatments. This chart of expected financial results demonstrates an upward trend, where the value of 0.18 serves as the current metric. Growth is based on the repurposing of known molecules and the rapid expansion of sales for approved drugs, which minimizes risks and protects investor capital.
Analytical breakdowns for Axsome Therapeutics
- share price and consensus valuation forecast:
- market capitalization data:
- book capitalization information:
- debt obligations and liquidity statistics:
Debt to Equity Axsome Therapeutics|AXSM - Long-Term Debt to Equity Ratio|Short-Term Debt to Capital Axsome Therapeutics Inc|AXSM - Company Cumulative Debt|Debt to Book Value Axsome Therapeutics|AXSM - Company Long-Term Loans and Borrowings|Company Current Liabilities Axsome Therapeutics|Quick Ratio axsome.com
- net income and valuation ratios data:
AXSM - Final Profit|Projected Future Earnings Axsome Therapeutics|AXSM - Market Cap to Earnings|Future Price to Earnings Axsome Therapeutics, Inc.|AXSM - Growth-Adjusted Payback Ratio|EV/EBITDA Multiple Axsome Therapeutics|AXSM - Operating profit EBITDA|Earnings per share for the last twelve months Axsome Therapeutics|AXSM - Earnings per one share for the last 12 months|Quarterly EPS earnings growth axsome.com|AXSM - Earnings per share growth rate in current year|Expected earnings per share growth for next year Axsome Therapeutics
- revenue and sales details:
Fundamental company analysis:Axsome Therapeutics
Projected financial results for Axsome Therapeutics (AXSM) reflect the monetization of patent protection for CNS drugs under strict FDA oversight. This indicator aggregates expected net income, measuring the business's ability to convert regulatory approvals into actual cash flow, which allows investors to differentiate fundamental growth from temporary market fluctuations and assess the risk of overpaying for the asset.
Competitor analysis for Axsome Therapeutics
BIIB (Biogen Inc.) - Projected Future Earnings|Projected Future Earnings neurocrine.com|Future Profit RGC (Regencell Bioscience Holdings Limited)|ACADIA Pharma - Net Profit Forecast|Expected Profit Xenon Pharmaceuticals Inc XENE|Company Profit Forecast Viking Therapeutics Corp (VKTX)|SUPN - Expected Profit|Expected Net Profit catalystpharma.com|Denali Therapeutics Inc. (DNLI) - Expected Profit|Future Profit Harmony Biosciences Inc|BHVN (Biohaven Pharmaceutical) - Projected Future Earnings|Expected Net Profit Amylyx Corp AMLX|Future Profit TRVI (Trevi Therapeutics)|PRAX (praxismedicines.com) - Expected Net Income|Anavex Life Sciences Corp. - Future Profit|Future Net Profit CBLL (CeriBell Inc)|Prothena Biosciences - Projected Future Earnings|Expected Net Income ALEC (Alector, Inc.)|ANNX: Projected Future Earnings|Expected Net Profit Omeros (OMER)|Expected Profit Neurogene|ACIU: Expected Net Income|Projected Future Earnings VYGR|Projected Future Earnings Neumora Corp (NMRA)|Expected Profit Scilex Holding Company SCLX|TVGN (tevogen.com) - Forward Earnings|Alpha Cognition Corp - Projected Future Earnings|Expected Net Profit cogrx.com|IKT (Inhibikase) - Future Profit|Cassava Pharma (SAVA) - Projected Future Earnings|Future Profit ASRT|COYA (Coya) - Future Net Profit|Projected Future Earnings VTGN|Company Profit Forecast ovidrx.com|Projected Future Earnings ABOS (Acumen Pharma)|CRVO - Future Profit|ATHE - Expected Profit|Company Profit Forecast Clene Inc. CLNN|PEPG: Projected Future Earnings|jupiterneurosciences.com (JUNS) - Projected Future Earnings|Future Profit RLMD|Net Profit Forecast ANVS (Annovis Bio Corporation)|Expected Profit Grace Therapeutics, Inc. (GRCE)|Company Profit Forecast fireflyneuro.com|Expected Profit Klotho Neurosciences KLTO|NRSN - Future Profit|RVPH - Expected Profit|MTVA (MetaVia Inc) - Net Profit Forecast|NRXS: Projected Future Earnings|Expected Net Profit Helius Medical Technologies (HSDT)|Future Profit PASG|Projected Future Earnings Neuphoria|Expected Profit Minerva Neurosciences Corp (NERV)|ATHA (Athira Pharma Corp) - Expected Net Income|Expected Profit Addex Therapeutics ADXN|Alzamend Neuro Inc. (ALZN) - Expected Net Profit|Cyclerion - Projected Future Earnings|PTIX - Projected Future Earnings|KTTA (pasitheaclinics.com) - Future Profit|Net Profit Forecast CRGT|Expected Profit Avenue Therapeutics|brainstorm-cell.com (BCLI) - Company Profit Forecast|Expected Profit Cara Therapeutics (CARA)|CHRO - Expected Net Profit|Expected Profit Eliem Therapeutics Inc. ELYM|ITCI - Future Profit|Longboard Pharmaceuticals - Projected Future Earnings|Expected Net Profit marinuspharma.com|NKGN (NKGen Biotech) - Future Profit|NeuroBo Pharmaceuticals Inc - Expected Net Income|Future Profit SAGE|SNPX (Synaptogenix, Inc) - Future Net Profit|Projected Future Earnings TRVN|VIGL (vigilneuro.com) - Expected Net Income|Projected Future Earnings WENA (Anew Medical, Inc.)|Cerevel Therapeutics Inc (CERE) - Expected Net Profit
